Two studies reveal new variant of mesothelioma
Researchers working independently at the University of Hawaii Cancer Centre and the National Cancer Institute,…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
AI effective at detecting advanced breast cancer, but misses some cases
A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14%…
Plant-based nutrient improves immune cells’ ability to fight cancer
In a new study, researchers from the University of Chicago, USA, discovered that zeaxanthin, a…
New genetic biomarker flags aggressive brain tumours
Clinicians typically classify meningiomas — the most common type of brain tumour — into three…
Researchers develop first-of-its-kind RNA tool to advance cancer and infectious disease research and treatment
Researchers at the Antimicrobial Resistance (AMR) interdisciplinary research group of the Singapore-MIT Alliance for Research and Technology (SMART),…
Shorter, less intense radiation-chemo regimen effective for HPV-linked oropharyngeal cancer
A study has found that a shortened, less intense course of radiation and chemotherapy after minimally…
First genetically engineered cancer model in naked mole rats developed
Researchers have created the first genetically engineered model of lung cancer in naked mole rats,…
WCLC 2025: Study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small…
WCLC 2025: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
An analysis from the Phase 3 CheckMate 77T trial confirms that perioperative nivolumab does not…
WCLC 2025: New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously…